17 December 2025VideosEuropeCharles Larsen, McDermott Will & Emery | Marcus Dalton, Curevac | Shohta Ueno, Regeneron | Rachel Fetches, HGF | Edger Brinkman, Unified Patent Court

WATCH: Behind the scenes of big ticket litigation — lessons from the courts

High-value IP disputes are reshaping life sciences litigation, with perspectives from McDermott Will & Emery, Curevac, Regeneron, HGF, and the UPC.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

IP finance gap risks startup exodus, EUIPO warns

13 April 2026 New report finds that just 13% of IP-owning firms have sought financing through their assets, with billions in potential funding left untapped, as structural barriers persist.

Europe

UK patent office adopts EPO standards for AI inventions

9 April 2026 In light of Emotional Perception AI, the UKIPO has rewritten the rules for “mixed inventions". Matt Jefferies and Eric McNeil of Marks & Clerk explore what this pivot means for applicants protecting their AI technology.

Europe

UPC refuses early knockout in Illumina–Element dispute

2 April 2026 A Lisbon judge rejects a bid to strike out the case over a drafting issue, offering insight into the court’s high bar for early dismissal.

More features

Baker McKenzie strengthens IP bench with new German lead

Novo Nordisk and OpenAI strike AI deal to boost drug discovery

IP finance gap risks startup exodus, EUIPO warns

Patent office fee increases: What applicants must know

UK patent office adopts EPO standards for AI inventions

Gilead to pay up to $5bn for antibody-drug conjugates push

Closing the women's health gap offers ‘benefits for all’

European patent offices raise fees

WATCH: Behind the scenes of big ticket litigation — lessons from the courts

More on this story

Editor's picks

Editor's picks

More features